Test More of Your Knowledge of CLL Presented at ASCO 2024!
Do you remember the CLL research presented at ASCO 2024? Test your knowledge with new questions and see how you rank!
Aug 20, 2024
MEETING BRIEF
ASCO 2024: Chronic Lymphocytic Leukemia
The latest news from ASCO 2024 focused on chronic lymphocytic leukemia (CLL) including abstracts, features, and helpful conference information.
Test Your Knowledge of CLL Presented at ASCO 2024!
Test Your Knowledge of CLL Presented at ASCO 2024!
Do you remember the CLL research presented at ASCO 2024? Test your knowledge now and see how you rank!
ASCO 2024 eBook on CLL
ASCO 2024 eBook on CLL
A curated eBook featuring ASCO 2024 CLL-focused studies, findings, and expert opinions.
Targeted Sequencing Adds Value to FISH for Detecting Genetic Alterations in CLL
Targeted Sequencing Adds Value to FISH for Detecting Genetic Alterations in CLL
Researchers evaluated whether targeted next-generation sequencing was comparable to fluorescence in situ hybridization for detecting genetic alterations in CLL.
Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy
Adding a Kinase to Pembrolizumab May Increase CLL Treatment Efficacy
Adding BCR kinase inhibitor ibrutinib or idelalisib to monoclonal antibody pembrolizumab increases treatment efficacy in CLL with Richter transformation.
Advertisement
PW QUIZ
Advertisement
Evaluating Safety & Outcomes of Rapid BCL-2 Inhibitor Titration for CLL
Evaluating Safety & Outcomes of Rapid BCL-2 Inhibitor Titration for CLL
Researchers at the 2024 ASCO Annual Meeting studied the rapid titration of venetoclax for chronic lymphocytic leukemia and mantle cell lymphoma.
AI and ML Show Promise in Targeting Therapies for Chronic Lymphocytic Leukemia
AI and ML Show Promise in Targeting Therapies for Chronic Lymphocytic Leukemia
AI and ML advances chronic lymphocytic leukemia therapies.
Correlation of Treatment Response with PFS and OS in Patients with R/R CLL or SLL
Correlation of Treatment Response with PFS and OS in Patients with R/R CLL or SLL
The following is a summary of “Association between treatment (tx) response and PFS and OS in...
Analyzing CR as a Surrogate Endpoint for PFS in R/R CLL/SLL
Analyzing CR as a Surrogate Endpoint for PFS in R/R CLL/SLL
The following is a summary of “Evaluating CR as a surrogate endpoint for PFS in R/R chronic...
Stay connected to the latest news with Physician’s Weekly
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.
